Published in J Exp Clin Cancer Res on August 05, 2010
Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res (2011) 1.25
Molecular predictors of gemcitabine response in pancreatic cancer. World J Gastrointest Oncol (2011) 0.96
TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes. Mol Cancer Res (2014) 0.88
Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer. World J Gastroenterol (2014) 0.82
Protein kinase Cα mediates erlotinib resistance in lung cancer cells. Mol Pharmacol (2015) 0.82
The kinase PKCα selectively upregulates interleukin-17A during Th17 cell immune responses. Immunity (2013) 0.81
Targeting protein kinase C subtypes in pancreatic cancer. Expert Rev Anticancer Ther (2015) 0.78
Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach. Biomed Res Int (2015) 0.77
Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance. Sci Rep (2016) 0.75
Protein kinase C isoforms in the normal pancreas and in pancreatic disease. Cell Signal (2017) 0.75
TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J (2002) 3.80
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol (2007) 2.69
Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res (2001) 2.29
Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res (2007) 2.28
Inhibition of TGFbeta signaling in cancer therapy. Curr Opin Genet Dev (2005) 1.78
The molecular basis of differential subcellular localization of C2 domains of protein kinase C-alpha and group IVa cytosolic phospholipase A2. J Biol Chem (2003) 1.44
Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res (1997) 1.34
TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol (2008) 1.31
Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Oncogene (2005) 1.25
Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. J Biol Chem (1993) 1.23
Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta. Oncogene (2004) 1.23
Expression of Smad proteins in human colorectal cancer. Int J Cancer (1999) 1.21
Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Clin Cancer Res (2002) 1.13
Smad4-independent TGF-beta signaling in tumor cell migration. Cells Tissues Organs (2007) 1.13
Protein kinase C alpha expression in breast and ovarian cancer. Oncology (2004) 1.07
Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands. Exp Cell Res (2006) 1.07
Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway. Biochem Biophys Res Commun (2008) 1.04
Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not c-raf-1 protein. Int J Cancer (1996) 1.01
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate (2008) 0.98
Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells. Arch Pharm Res (2006) 0.93
Induction and subcellular localization of protein kinase C isozymes following renal ischemia. Kidney Int (2001) 0.93
Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis. Clin Exp Metastasis (2005) 0.91
P-glycoprotein, multidrug resistance and protein kinase C. Stem Cells (1996) 0.90
MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer. Anticancer Res (2007) 0.89
Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells. Br J Cancer (2000) 0.89
Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta. Cancer Surv (1991) 0.86
Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Clin Cancer Res (1995) 0.86
Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha. Eur J Biochem (1996) 0.86
Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3. Endocrinology (1997) 0.85
The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer. Biochim Biophys Acta (2007) 0.85
Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values. Cancer Invest (2006) 0.83
Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells. Biochem Pharmacol (1994) 0.83
Development and validation of a phosphorylated SMAD ex vivo stimulation assay. Biomarkers (2007) 0.83
Over-expression of TGF-beta1 in Smad4-deficient human oral carcinoma cells causes tumour regression in vivo by mechanisms that sensitize cells to apoptosis. J Pathol (2005) 0.83
Differential expression and activity of phosphatases and protein kinases in adriamycin sensitive and resistant human breast cancer MCF-7 cells. Int J Oncol (1998) 0.81
p21Waf1/Cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line. Int J Cancer (1999) 0.80
Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model. Gynecol Oncol (2008) 0.79
Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism. Invest New Drugs (1997) 0.78
Role of TGF beta in the anti-estrogen response/resistance of human breast cancer. J Mammary Gland Biol Neoplasia (1996) 0.78
Tumor microenvironment: hypoxia and buffer capacity for immunotherapy. Med Hypotheses (2007) 0.77
Unique phosphorylation of protein kinase C-alpha in PC12 cells induces resistance to translocation and down-regulation. J Biol Chem (1996) 0.77
Preparation and characterization of polyclonal antibodies against ARL-1 protein. World J Gastroenterol (2003) 0.77
Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines. Biochem Pharmacol (1998) 0.76
LAB: a new membrane-associated adaptor molecule in B cell activation. Nat Immunol (2003) 1.58
Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol (2012) 1.53
Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis. J Clin Invest (2014) 1.45
Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver. Proc Natl Acad Sci U S A (2008) 1.38
Doctor stabbed to death two days after warning in The Lancet. Lancet (2011) 1.37
Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer (2010) 1.28
A retrospective survey of research design and statistical analyses in selected Chinese medical journals in 1998 and 2008. PLoS One (2010) 1.15
An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response. J Exp Med (2006) 1.15
The role of the LAT-PLC-gamma1 interaction in T regulatory cell function. J Immunol (2010) 1.14
Statistical reporting in Chinese biomedical journals. Lancet (2009) 1.12
Linker for activation of B cells: a functional equivalent of a mutant linker for activation of T cells deficient in phospholipase C-gamma1 binding. J Immunol (2004) 1.12
The importance of three membrane-distal tyrosines in the adaptor protein NTAL/LAB. J Biol Chem (2004) 1.08
Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia (2002) 1.06
Facing up to the threat in China. Lancet (2010) 1.01
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology (2012) 0.98
The essential role of LAT in thymocyte development during transition from the double-positive to single-positive stage. J Immunol (2009) 0.98
The importance of LAT in the activation, homeostasis, and regulatory function of T cells. J Biol Chem (2010) 0.98
Inhibition of LDH-A by lentivirus-mediated small interfering RNA suppresses intestinal-type gastric cancer tumorigenicity through the downregulation of Oct4. Cancer Lett (2012) 0.98
Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype. Int J Oncol (2011) 0.96
Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology (2009) 0.94
Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis (2008) 0.94
Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. Gastric Cancer (2013) 0.93
Overexpression of ATA1/SLC38A1 predicts future recurrence and death in Chinese patients with hilar cholangiocarcinoma. J Surg Res (2010) 0.91
ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth. PLoS One (2011) 0.89
Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells. Biochem Biophys Res Commun (2008) 0.89
Activation-induced endocytosis of the raft-associated transmembrane adaptor protein LAB/NTAL in B lymphocytes: evidence for a role in internalization of the B cell receptor. Int Immunol (2006) 0.89
Role of LAT in the granule-mediated cytotoxicity of CD8 T cells. Mol Cell Biol (2012) 0.88
Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. J Surg Oncol (2011) 0.87
Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncol Rep (2013) 0.86
Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression. BMC Cancer (2013) 0.85
Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers. BMC Cancer (2014) 0.85
Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells. Oncol Rep (2011) 0.84
Downregulation of PCDH9 predicts prognosis for patients with glioma. J Clin Neurosci (2012) 0.83
Lymphangiogenic and angiogentic microvessel density in gallbladder carcinoma. Hepatogastroenterology (2011) 0.82
Regulation of RasGRP1 function in T cell development and activation by its unique tail domain. PLoS One (2012) 0.82
Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis. Mol Cancer (2014) 0.82
Neurotrophic Factor Artemin Promotes Invasiveness and Neurotrophic Function of Pancreatic Adenocarcinoma In Vivo and In Vitro. Pancreas (2015) 0.80
Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. Clin Exp Metastasis (2015) 0.80
[Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi (2002) 0.79
The importance of the Erk pathway in the development of linker for activation of T cells-mediated autoimmunity. J Immunol (2012) 0.79
[Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes]. Zhonghua Yi Xue Za Zhi (2002) 0.79
The role of LAT-PLCγ1 interaction in γδ T cell development and homeostasis. J Immunol (2014) 0.79
Interleukin-4 -590T/C polymorphism influences the susceptibility to nonsmall cell lung cancer. DNA Cell Biol (2011) 0.79
Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. FEBS J (2012) 0.78
A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation, and autoimmunity. Immunol Res (2011) 0.78
Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis. Med Oncol (2014) 0.78
Analysis of tumor-induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus. Cancer Sci (2012) 0.78
Computational prediction of the specificities of proteasome interaction with antigen protein. Cell Mol Immunol (2009) 0.77
The requirement of linker for activation of T cells in the primary and memory responses of CD8 T cells. J Immunol (2013) 0.77
HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells. Biochem Biophys Res Commun (2009) 0.77
Overexpression of p-4ebp1 in Chinese gastric cancer patients and its correlation with prognosis. Hepatogastroenterology (2012) 0.76
Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma. Med Oncol (2014) 0.75
NEDD4 Depletion Inhibits Hepatocellular Carcinoma Growth via Targeting PTEN. Cell Physiol Biochem (2016) 0.75
[Ziehl-Neelsen-Victoria blue-iodine green compound staining method showing leprotic bacillus]. Beijing Da Xue Xue Bao (2003) 0.75
[Consensus of Chinese experts on detection of related drive genes in target therapy of non-small cell lung cancer]. Zhonghua Bing Li Xue Za Zhi (2016) 0.75
Microadenocarcinoma of the pancreas. Eur J Gastroenterol Hepatol (2009) 0.75
Porous nanoapatite scaffolds synthesized using an approach of interfacial mineralization reaction and their bioactivity. J Biomed Mater Res B Appl Biomater (2014) 0.75
[Clear cell chondrosarcoma of cricoid cartilage: report of a case]. Zhonghua Bing Li Xue Za Zhi (2014) 0.75
[Effect of vitreous-cryopreservation on in vivo implantation of tissue engineered tendons]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2009) 0.75